Abstract:Catecholaminergic polymorphic ventricular tachycardia (CPVT) predisposes to ventricular arrhythmia due to altered Ca 2+ homeostasis and can arise from ryanodine receptor ( RyR2 ) mutations including RyR2-P2328S . Previous reports established that homozygotic murine RyR2 - P2328S ( RyR2 S/S ) hearts show an atrial arrhythmic phenotype associated with reduced action potential (AP) conduction velocity and sodium channel (Na v 1.5) expression. We now relate ventricular arrhythmogenicity and slowed AP conduction in RyR2 S/S hearts to connexin-43 (Cx43) and Na v 1.5 expression and Na + current ( I Na ). Stimulation protocols applying extrasystolic S2 stimulation following 8 Hz S1 pacing at progressively decremented S1S2 intervals confirmed an arrhythmic tendency despite unchanged ventricular effective refractory periods (VERPs) in Langendorff-perfused RyR2 S/S hearts. Dynamic pacing imposing S1 stimuli then demonstrated that progressive reductions of basic cycle lengths (BCLs) produced greater reductions in conduction velocity at equivalent BCLs and diastolic intervals in RyR2 S/S than WT, but comparable changes in AP durations (APD 90 ) and their alternans. Western blot analyses demonstrated that Cx43 protein expression in whole ventricles was similar, but Na v 1.5 expression in both whole tissue and membrane fractions were significantly reduced in RyR2 S/S compared to wild-type (WT). Loose patch-clamp studies similarly demonstrated reduced I Na in RyR2 S/S ventricles. We thus attribute arrhythmogenesis in RyR2 S/S ventricles resulting from arrhythmic substrate produced by reduced conduction velocity to downregulated Na v 1.5 reducing I Na , despite normal determinants of repolarization and passive conduction. The measured changes were quantitatively compatible with earlier predictions of linear relationships between conduction velocity and the peak I Na of the AP but nonlinear relationships between peak I Na and maximum Na + permeability.

RyR1 mutation associated with malignant hyperthermia facilitates catecholaminergic stress‐included arrhythmia via mitochondrial injury and oxidative stress (893.8)

Reduced Threshold for Luminal Ca2+ Activation of RyR1 Underlies a Causal Mechanism of Porcine Malignant Hyperthermia

RyR 2 Mutations Linked to Ventricular Tachycardia and Sudden Death Reduce the Threshold for Store-Overload-induced Ca 2 Release ( SOICR )

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

Loss of Luminal Ca 2+ Activation in the Cardiac Ryanodine Receptor is Associated with Ventricular Fibrillation and Sudden Death

Enhanced Store Overload–Induced Ca 2+ Release and Channel Sensitivity to Luminal Ca 2+ Activation Are Common Defects of RyR2 Mutations Linked to Ventricular Tachycardia and Sudden Death

Characterization of a Novel Mutation in the Cardiac Ryanodine Receptor That Results in Catecholaminergic Polymorphic Ventricular Tachycardia

An Advance in the study of ryanodine receptor mutations and malignant hyperthermia

Bioenergetic Defects in Muscle Fibers of RYR1 Mutant Knock-in Mice Associated with Malignant Hyperthermia

Endoplasmic Reticulum Ca2+ Measurements Reveal That the Cardiac Ryanodine Receptor Mutations Linked to Cardiac Arrhythmia and Sudden Death Alter the Threshold for Store-Overload-induced Ca2+ Release.

Impaired Interaction Between Skeletal Ryanodine Receptors In Malignant Hyperthermia

Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.

Reduced Threshold for Store Overload-Induced Ca2+ Release is a Common Defect of RyR1 Mutations Associated with Malignant Hyperthermia and Central Core Disease.

Arrhythmogenic mechanism of a novel ryanodine receptor mutation underlying sudden cardiac death

Cardiac Hypertrophy and Arrhythmia in Mice Induced by a Mutation in Ryanodine Receptor 2

Novel Ryanodine Receptor Mutation Associated With Hypertrophic Cardiomyopathy Induces Cardiac Remodeling and Arrhythmia in Mice

The RyR2-P2328S Mutation Downregulates Nav1.5 Producing Arrhythmic Substrate in Murine Ventricles

Novel RyR2 Mutation (G3118R) is Associated with Autosomal Recessive Ventricular Fibrillation and Sudden Death: Clinical, Functional, and Computational Analysis

Reduced Expression of Cardiac Ryanodine Receptor Protects Against Stress-Induced Ventricular Tachyarrhythmia, but Increases the Susceptibility to Cardiac Alternans.

Sudden Death Due to Malignant Hyperthermia with a Mutation of RYR1: Autopsy, Morphology and Genetic Analysis.

Abstract 3768: the Deficiency of Ryanodine Receptor Type 2 Accelerates Transition from Adaptive Cardiac Hypertrophy to Dysfunction During Pressure Overload